Showing results (271-280 of 624) with videos related to
Sort By:
Pageof 63
Journal of Thrombosis and Haemostasis : JTH|June 8, 2012
ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpuraG Bettoni, R Palla, C Valsecchi, et al.Drug and Alcohol Dependence|December 27, 2023
Effects of inhaled low-concentration xenon gas on naltrexone-precipitated withdrawal symptoms in morphine-dependent miceMarc J Kaufman, Edward G Meloni, Alaa N Qrareya, et al.Bone Marrow Transplantation|November 1, 1996
Autologous bone marrow transplantation in children with acute myeloblastic leukemia: report from the Italian National Pediatric Registry (AIEOP-BMT)M Vignetti, R Rondelli, F Locatelli, et al.Annals of the New York Academy of Sciences|August 8, 2006
Role of the bed nucleus of the stria terminalis (BST) in the expression of conditioned fearEdward G Meloni, Alexandra Jackson, Lyle P Gerety, et al.Mycoses|June 6, 2009
Classic pyomyositis of the extremities as an unusual manifestation of Blastomyces dermatitidis: a report of two casesMichael Y Lin, Shingo Chihara, Kimberly Y Smith, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 1, 1993
Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patientsA Micozzi, M Nucci, M Venditti, et al.Critical Reviews in Oncology/Hematology|March 26, 2011
Time for a new era in the evaluation of targeted therapies for patients with chronic myeloid leukemia: inclusion of quality of life and other patient-reported outcomesF Efficace, K Cocks, M Breccia, et al.Cancer|May 15, 1996
Risk factors for essential thrombocythemia: A case-control study. Italian Leukemia Study GroupA Mele, G Visani, A Pulsoni, et al.Leukemia & Lymphoma|January 1, 1994
HLA typing in hairy cell leukemiaL Annino, A Ferrari, L Laurenti, et al.Leukemia Research|January 1, 1984
Sequential combination of high dose ARA-C (HiDAC) and asparaginase (ASP) for the treatment of advanced acute leukemia and lymphomaS Amadori, G Papa, G Avvisati, et al.Pageof 63